Annual Cash & Cash Equivalents
$3.59 M
-$5.76 M-61.62%
March 1, 2024
Summary
- As of February 26, 2025, VRAX annual cash & cash equivalents is $3.59 million, with the most recent change of -$5.76 million (-61.62%) on March 1, 2024.
- During the last 3 years, VRAX annual cash & cash equivalents has risen by +$3.57 million (+20293.18%).
- VRAX annual cash & cash equivalents is now -61.62% below its all-time high of $9.35 million, reached on March 31, 2023.
Performance
VRAX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.29 M
+$3.70 M+103.00%
September 1, 2024
Summary
- As of February 26, 2025, VRAX quarterly cash and cash equivalents is $7.29 million, with the most recent change of +$3.70 million (+103.00%) on September 1, 2024.
- Over the past year, VRAX quarterly cash and cash equivalents has stayed the same.
- VRAX quarterly cash and cash equivalents is now -22.10% below its all-time high of $9.35 million, reached on March 31, 2023.
Performance
VRAX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VRAX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.6% | 0.0% |
| 3 y3 years | +10000.0% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
VRAX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.6% | >+9999.0% | -22.1% | >+9999.0% |
| 5 y | 5-year | -61.6% | >+9999.0% | -22.1% | >+9999.0% |
| alltime | all time | -61.6% | >+9999.0% | -22.1% | >+9999.0% |
Virax Biolabs Group Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.29 M(+103.0%) |
| Mar 2024 | $3.59 M(-61.6%) | $3.59 M(-29.7%) |
| Sep 2023 | - | $5.11 M(-45.4%) |
| Mar 2023 | $9.35 M | $9.35 M(+104.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4.57 M(>+9900.0%) |
| Mar 2022 | $21.80 K(+23.9%) | $21.80 K(+86.3%) |
| Sep 2021 | - | $11.70 K(-33.5%) |
| Mar 2021 | $17.60 K(-22.1%) | $17.60 K |
| Mar 2020 | $22.60 K | - |
FAQ
- What is Virax Biolabs Group Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual cash & cash equivalents year-on-year change?
- What is Virax Biolabs Group Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited quarterly cash and cash equivalents year-on-year change?
What is Virax Biolabs Group Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of VRAX is $3.59 M
What is the all time high annual cash & cash equivalents for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual cash & cash equivalents is $9.35 M
What is Virax Biolabs Group Limited annual cash & cash equivalents year-on-year change?
Over the past year, VRAX annual cash & cash equivalents has changed by -$5.76 M (-61.62%)
What is Virax Biolabs Group Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VRAX is $7.29 M
What is the all time high quarterly cash and cash equivalents for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high quarterly cash and cash equivalents is $9.35 M
What is Virax Biolabs Group Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, VRAX quarterly cash and cash equivalents has changed by $0.00 (0.00%)